Small Study Suggests Antidepressant Fluvoxamine Could Treat COVID-19
Small Study Suggests Antidepressant Fluvoxamine Could Treat COVID-19 Silvia Pittman © The Mighty Medication capsule on blue background An antidepressant already on the market could pave the way toward more affordable and accessible treatment for people with a symptomatic COVID-19 infection. A new clinical trial using the psychiatric drug fluvoxamine (brand name Luvox) showed promise in a Washington University trial in reducing serious outcomes for people with the virus. Resea...
Eric Lenze Francis Collins Miguel Vela Washington University National Institute Of Health Mighty Medication
Source: msn.com